The study showed that three variables, including serum LCN2 level, body mass index (BMI), and low-density lipoprotein (LDL) cholesterol, are positively correlated with NAFLD. This evidence concerns the gene LCN2 and metabolic dysfunction-associated steatotic liver disease.